Innoget© 2018 Innoget

Showing all visible results for Medical Research

Anti-QSOX1 Antibody for Treating Cancer and Metastasis

Cancer, and especially cancer metastasis, is a leading cause of death worldwide. Research in recent years highlighted the importance of the extracellular matrix (ECM) surrounding the tumor in cancer progression metastasis f

Patents for licensing

Anti-QSOX1 Antibody for Treating Cancer and Metastasis
  • +20 hours
  • Hide post

Antibody Based Therapy to Treat Cancer and GI Related Diseases

A novel therapeutic antibody against MMP-7, with exceptional specificity, for the treatment of aggressive cancers. Although early programs targeting MMPs (matrix metalloproteins) were largely unsuccessful due to adverse side

Patents for licensing

Antibody Based Therapy to Treat Cancer and GI Related Diseases
  • +20 hours
  • Hide post

Detecting Necroptosis Activation via Exosome Analysis

Numerous medical conditions are related to inflammation, such as pancreatitis, psoriasis, inflammatory bowel disease, atherosclerosis, neurodegeneration, and more. However, determination of inflammation in the body, especia

Patents for licensing

Detecting Necroptosis Activation via Exosome Analysis
  • +21 hours
  • Hide post

Antidepressant targeting Astrocytes

A fast-acting antidepressant candidate whose pharmacological target is not a neuron receptor but an astrocyte channel. The technology is based on small molecules that modulate specific astrocyte channels showing antidepressiv

Patents for licensing

Antidepressant targeting Astrocytes
  • +3 weeks
  • Hide post

Chilean seaweed extract as a Nutraceutical Supplement with Health Benefits

A nutraceutical supplement and complementary approach in the prevention and treatment of insulin resistance and diabetes. It also has other effects observed in our preliminary studies, such as neuronal, vascular, and oxidativ

Patents for licensing

Chilean seaweed extract as a Nutraceutical Supplement with Health Benefits
  • +3 weeks
  • Hide post